Cargando…

Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival

There is increased production of plasmacytoid dendritic cells (pDCs) in the bone marrow (BM) of multiple myeloma (MM) patients and these favor Th22 cell differentiation. Here, we found that the frequency of interleukin (IL)-22(+)IL-17(−)IL-13(+) T cells is significantly increased in peripheral blood...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Lullo, Giulia, Marcatti, Magda, Heltai, Silvia, Brunetto, Emanuela, Tresoldi, Cristina, Bondanza, Attilio, Bonini, Chiara, Ponzoni, Maurilio, Tonon, Giovanni, Ciceri, Fabio, Bordignon, Claudio, Protti, Maria Pia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485827/ https://www.ncbi.nlm.nih.gov/pubmed/26155400 http://dx.doi.org/10.1080/2162402X.2015.1005460

Ejemplares similares

Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple Myeloma
por: Di Lullo, Giulia, et al.
Publicado: (2019)

Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment
por: Belloni, Daniela, et al.
Publicado: (2018)

The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer
por: Brunetto, Emanuela, et al.
Publicado: (2019)

ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies
por: Botrugno, Oronza A., et al.
Publicado: (2019)

Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide Gene
por: Casucci, Monica, et al.
Publicado: (2018)

Improving the safety of cell therapy with the TK-suicide gene
por: Greco, Raffaella, et al.
Publicado: (2015)

CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome
por: Arcangeli, Silvia, et al.
Publicado: (2022)

Minimal residual disease detection by next-generation sequencing in multiple myeloma: Promise and challenges for response-adapted therapy
por: Ferla, Valeria, et al.
Publicado: (2022)

Next-Generation Manufacturing Protocols Enriching T(SCM) CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients
por: Arcangeli, Silvia, et al.
Publicado: (2020)

A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells
por: Milan, Enrico, et al.
Publicado: (2015)

Predicting the Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: The Long and Winding Road toward Validated Immune Biomarkers
por: Forcina, A., et al.
Publicado: (2013)

ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially
por: Vantaggiato, Chiara, et al.
Publicado: (2006)

CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses
por: Bove, Camilla, et al.
Publicado: (2023)

Estimating Point and Interval Frequency of Antigen-Specific CD4(+) T Cells Based on Short In Vitro Expansion and Improved Poisson Distribution Analysis
por: Di Lullo, Giulia, et al.
Publicado: (2012)

P965: STEM-CELL MOBILIZATION WITH CYCLOPHOSPHAMIDE 4 G/M2 ALLOWS COLLECTION OF HIGH NUMBERS OF CD34+ CELLS AFTER DARA-VTD INDUCTION FOR MULTIPLE MYELOMA
por: Perini, Tommaso, et al.
Publicado: (2023)

Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma
por: Calcinotto, Arianna, et al.
Publicado: (2015)

Higher cyclophosphamide dose grants optimal stem cell collection after daratumumab-based induction in multiple myeloma
por: Liberatore, Carmine, et al.
Publicado: (2023)

Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma
por: Trudu, Matteo, et al.
Publicado: (2022)

IL-10-Engineered Human CD4(+) Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism
por: Locafaro, Grazia, et al.
Publicado: (2017)

Suicide Gene Therapy to Increase the Safety of Chimeric Antigen Receptor-Redirected T Lymphocytes
por: Casucci, Monica, et al.
Publicado: (2011)

Marginal zone lymphoma: Diagnostic challenges among different entities
por: Bongiovanni, Lucia, et al.
Publicado: (2018)

Clinical development of CAR T cells—challenges and opportunities in translating innovative treatment concepts
por: Hartmann, Jessica, et al.
Publicado: (2017)

Ex-Vivo Dynamic 3-D Culture of Human Tissues in the RCCS™ Bioreactor Allows the Study of Multiple Myeloma Biology and Response to Therapy
por: Ferrarini, Marina, et al.
Publicado: (2013)

Correction: Ex-Vivo Dynamic 3-D Culture of Human Tissues in the RCCS™ Bioreactor Allows the Study of Multiple Myeloma Biology and Response to Therapy
por: Ferrarini, Marina, et al.
Publicado: (2013)

PB2575: HIGH INCIDENCE OF RESPIRATORY TRACT INFECTIONS FOLLOWING COVID-19 WAVES IN PATIENTS WITH PLASMA CELL DYSCRASIAS
por: Farina, Francesca, et al.
Publicado: (2023)

A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia
por: Pierini, Valentina, et al.
Publicado: (2022)

Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics
por: Tavel, Laurette, et al.
Publicado: (2016)

Hypoxia inducible factor-1α regulates a pro-invasive phenotype in acute monocytic leukemia
por: Migliavacca, Jessica, et al.
Publicado: (2016)

Reduction of Prep1 Levels Affects Differentiation of Normal and Malignant B Cells and Accelerates Myc Driven Lymphomagenesis
por: Iotti, Giorgio, et al.
Publicado: (2012)

RESCUE OF HIPPO CO-ACTIVATOR YAP1 TRIGGERS DNA DAMAGE-INDUCED APOPTOSIS IN HEMATOLOGICAL CANCERS
por: Cottini, Francesca, et al.
Publicado: (2014)

A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
por: Lepore, Marco, et al.
Publicado: (2014)

Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis
por: Biavasco, Riccardo, et al.
Publicado: (2021)

miR-22 suppresses DNA ligase III addiction in multiple myeloma
por: Caracciolo, Daniele, et al.
Publicado: (2018)

HLA-G Expression on Blasts and Tolerogenic Cells in Patients Affected by Acute Myeloid Leukemia
por: Locafaro, Grazia, et al.
Publicado: (2014)

Defibrotide Prophylaxis of Sinusoidal Obstruction Syndrome in Adults Treated With Inotuzumab Ozogamicin Prior to Hematopoietic Stem Cell Transplantation
por: Giglio, Fabio, et al.
Publicado: (2022)

Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs
por: Pittari, Gianfranco, et al.
Publicado: (2017)

Poor Hematopoietic Stem Cell Mobilizers in Multiple Myeloma: a Single Institution Experience.
por: Ruiz-Delgado, Guillermo J., et al.
Publicado: (2010)

Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma
por: Mastorci, Katy, et al.
Publicado: (2016)

mTOR pathway activation in multiple myeloma cell lines and primary tumour cells: pomalidomide enhances cytoplasmic-nuclear shuttling of mTOR protein
por: Guglielmelli, Tommasina, et al.
Publicado: (2015)

Variant Burkitt-type translocation (8;22)(q24;q11) in plasma cell myeloma
por: Kim, Hanah, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4q7is679qoda0pk6icsiqptnbp